Is lower LV mass during antihypertensive treatment associated with lower rates of clinical end points in patients with essential hypertension and baseline electrocardiographic LV hypertrophy?
Reduction in left ventricular mass during antihypertensive therapy provides prognostic benefits independent of blood pressure reduction.
In patients with essential hypertension and baseline electrocardiographic LV hypertrophy, lower LV mass during antihypertensive treatment is associated with lower rates of clinical end points, additional to effects of blood pressure lowering and treatment modality.
Richard B. Devereux (Tue,) studied this question.